| First Author | Joshi JC | Year | 2025 |
| Journal | iScience | Volume | 28 |
| Issue | 2 | Pages | 111878 |
| PubMed ID | 40041768 | Mgi Jnum | J:368667 |
| Mgi Id | MGI:7869134 | Doi | 10.1016/j.isci.2025.111878 |
| Citation | Joshi JC, et al. (2025) RGS2 is an innate immune checkpoint for suppressing Galphaq-mediated IFNgamma generation and lung injury. iScience 28(2):111878 |
| abstractText | Interferon gamma (IFNgamma), a type II interferon, augments tissue inflammation following infections, leading to lethal acute lung injury (ALI), yet the mechanisms controlling IFNgamma generation in the lungs remain elusive. Here, we identified regulator of G protein signaling 2 (RGS2) as a gatekeeper of the lung's IFNgamma levels during infections. Deletion of RGS2 sustained an increase in IFNgamma levels in macrophages, leading to unresolvable inflammatory lung injury. This response was not seen in RGS2 null chimeric mice receiving wild-type (WT) bone marrow or the RGS2 gene in alveolar macrophages (AMs) or IFNgamma-blocking antibody. RGS2 functioned by suppressing Galphaq-mediated IFNgamma generation and AM inflammatory signaling. Thus, the inhibition of Galphaq blocked IFNgamma generation in AMs and rewired AM transcriptomes from an inflammatory to a reparative phenotype in RGS2 null mice, pointing to the RGS2-Galphaq axis as a potential target for suppressing inflammatory injury. |
